AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
119 hedge funds and large institutions have $683M invested in Accelerate Diagnostics in 2017 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 51 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
20% less call options, than puts
Call options by funds: $7.96M | Put options by funds: $9.98M
Holders
119
Holding in Top 10
6
Calls
$7.96M
Puts
$9.98M
Top Buyers
| 1 | +$22M | |
| 2 | +$14.2M | |
| 3 | +$12.9M | |
| 4 |
Axa
Paris,
France
|
+$8.44M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$7.62M |
Top Sellers
| 1 | -$1.98M | |
| 2 | -$1.76M | |
| 3 | -$967K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$731K |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$612K |